Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Bérubé NG[au]:

Epigenetic Etiology of Intellectual Disability. Iwase S et al. J Neurosci. (2017)

Emerging roles of ATRX in cancer. Watson LA et al. Epigenomics. (2015)

CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. Elbert A et al. J Neurosci. (2019)

Search results

Items: 40

1.

Inactivation of ATRX in forebrain excitatory neurons affects hippocampal synaptic plasticity.

Gugustea R, Tamming RJ, Martin-Kenny N, Bérubé NG, Leung LS.

Hippocampus. 2019 Nov 12. doi: 10.1002/hipo.23174. [Epub ahead of print]

PMID:
31713968
2.

CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons.

Elbert A, Vogt D, Watson A, Levy M, Jiang Y, Brûlé E, Rowland ME, Rubenstein J, Bérubé NG.

J Neurosci. 2019 Jan 2;39(1):177-192. doi: 10.1523/JNEUROSCI.3496-17.2018. Epub 2018 Oct 30.

3.

Inactivation of hepatic ATRX in Atrx Foxg1cre mice prevents reversal of aging-like phenotypes by thyroxine.

Rowland ME, Jiang Y, Beier F, Bérubé NG.

Aging (Albany NY). 2018 Jun 7;10(6):1223-1238. doi: 10.18632/aging.101462.

4.

Epigenetic Etiology of Intellectual Disability.

Iwase S, Bérubé NG, Zhou Z, Kasri NN, Battaglioli E, Scandaglia M, Barco A.

J Neurosci. 2017 Nov 8;37(45):10773-10782. doi: 10.1523/JNEUROSCI.1840-17.2017. Review.

5.

Identification of epigenetic signature associated with alpha thalassemia/mental retardation X-linked syndrome.

Schenkel LC, Kernohan KD, McBride A, Reina D, Hodge A, Ainsworth PJ, Rodenhiser DI, Pare G, Bérubé NG, Skinner C, Boycott KM, Schwartz C, Sadikovic B.

Epigenetics Chromatin. 2017 Mar 10;10:10. doi: 10.1186/s13072-017-0118-4. eCollection 2017.

6.

Mosaic expression of Atrx in the mouse central nervous system causes memory deficits.

Tamming RJ, Siu JR, Jiang Y, Prado MA, Beier F, Bérubé NG.

Dis Model Mech. 2017 Feb 1;10(2):119-126. doi: 10.1242/dmm.027482. Epub 2017 Jan 12.

7.

Emerging roles of ATRX in cancer.

Watson LA, Goldberg H, Bérubé NG.

Epigenomics. 2015;7(8):1365-78. doi: 10.2217/epi.15.82. Epub 2015 Dec 8. Review.

PMID:
26646632
8.

A new prescription for growth? Statins, cholesterol and cartilage homeostasis.

Bush JR, Bérubé NG, Beier F.

Osteoarthritis Cartilage. 2015 Apr;23(4):503-6. doi: 10.1016/j.joca.2015.01.002. Epub 2015 Jan 13. No abstract available.

9.

ATRX promotes gene expression by facilitating transcriptional elongation through guanine-rich coding regions.

Levy MA, Kernohan KD, Jiang Y, Bérubé NG.

Hum Mol Genet. 2015 Apr 1;24(7):1824-35. doi: 10.1093/hmg/ddu596. Epub 2014 Dec 1.

PMID:
25452430
10.

ATRX is required for maintenance of the neuroprogenitor cell pool in the embryonic mouse brain.

Ritchie K, Watson LA, Davidson B, Jiang Y, Bérubé NG.

Biol Open. 2014 Nov 13;3(12):1158-63. doi: 10.1242/bio.20148730.

11.

Analysis of neonatal brain lacking ATRX or MeCP2 reveals changes in nucleosome density, CTCF binding and chromatin looping.

Kernohan KD, Vernimmen D, Gloor GB, Bérubé NG.

Nucleic Acids Res. 2014 Jul;42(13):8356-68. doi: 10.1093/nar/gku564. Epub 2014 Jul 2.

12.

Implantation failure in female Kiss1-/- mice is independent of their hypogonadic state and can be partially rescued by leukemia inhibitory factor.

Calder M, Chan YM, Raj R, Pampillo M, Elbert A, Noonan M, Gillio-Meina C, Caligioni C, Bérubé NG, Bhattacharya M, Watson AJ, Seminara SB, Babwah AV.

Endocrinology. 2014 Aug;155(8):3065-78. doi: 10.1210/en.2013-1916. Epub 2014 May 30.

13.

Dual effect of CTCF loss on neuroprogenitor differentiation and survival.

Watson LA, Wang X, Elbert A, Kernohan KD, Galjart N, Bérubé NG.

J Neurosci. 2014 Feb 19;34(8):2860-70. doi: 10.1523/JNEUROSCI.3769-13.2014.

14.

Loss of ATRX does not confer susceptibility to osteoarthritis.

Solomon LA, Russell BA, Makar D, Bérubé NG, Beier F.

PLoS One. 2013 Dec 30;8(12):e85526. doi: 10.1371/journal.pone.0085526. eCollection 2013.

15.

Three dimensional dual labelled DNA fluorescent in situ hybridization analysis in fixed tissue sections.

Kernohan KD, Bérubé NG.

MethodsX. 2014 May 9;1:30-5. doi: 10.1016/j.mex.2014.04.001. eCollection 2014.

16.

Targeted loss of the ATR-X syndrome protein in the limb mesenchyme of mice causes brachydactyly.

Solomon LA, Russell BA, Watson LA, Beier F, Bérubé NG.

Hum Mol Genet. 2013 Dec 15;22(24):5015-25. doi: 10.1093/hmg/ddt351. Epub 2013 Jul 25.

PMID:
23892236
17.

Atrx deficiency induces telomere dysfunction, endocrine defects, and reduced life span.

Watson LA, Solomon LA, Li JR, Jiang Y, Edwards M, Shin-ya K, Beier F, Bérubé NG.

J Clin Invest. 2013 May;123(5):2049-63. doi: 10.1172/JCI65634. Epub 2013 Apr 8.

18.

Genetic and epigenetic dysregulation of imprinted genes in the brain.

Kernohan KD, Bérubé NG.

Epigenomics. 2010 Dec;2(6):743-63. doi: 10.2217/epi.10.61. Review.

PMID:
22122080
19.

Epigenetics, eh! A meeting summary of the Canadian Conference on Epigenetics.

Rodenhiser DI, Bérubé NG, Mann MR.

Epigenetics. 2011 Oct 1;6(10):1265-71. doi: 10.4161/epi.6.10.17491. Epub 2011 Oct 1.

PMID:
21931277
20.

ATRX in chromatin assembly and genome architecture during development and disease.

Bérubé NG.

Biochem Cell Biol. 2011 Oct;89(5):435-44. doi: 10.1139/o11-038. Epub 2011 Aug 18.

PMID:
21851155
21.

Mitotic chromosome condensation mediated by the retinoblastoma protein is tumor-suppressive.

Coschi CH, Martens AL, Ritchie K, Francis SM, Chakrabarti S, Berube NG, Dick FA.

Genes Dev. 2010 Jul 1;24(13):1351-63. doi: 10.1101/gad.1917610. Epub 2010 Jun 15.

22.

ATRX partners with cohesin and MeCP2 and contributes to developmental silencing of imprinted genes in the brain.

Kernohan KD, Jiang Y, Tremblay DC, Bonvissuto AC, Eubanks JH, Mann MR, Bérubé NG.

Dev Cell. 2010 Feb 16;18(2):191-202. doi: 10.1016/j.devcel.2009.12.017.

23.

Loss of ATRX in chondrocytes has minimal effects on skeletal development.

Solomon LA, Li JR, Bérubé NG, Beier F.

PLoS One. 2009 Sep 23;4(9):e7106. doi: 10.1371/journal.pone.0007106.

24.

Altered visual function and interneuron survival in Atrx knockout mice: inference for the human syndrome.

Medina CF, Mazerolle C, Wang Y, Bérubé NG, Coupland S, Gibbons RJ, Wallace VA, Picketts DJ.

Hum Mol Genet. 2009 Mar 1;18(5):966-77. doi: 10.1093/hmg/ddn424. Epub 2008 Dec 16.

PMID:
19088125
25.

Neuronal death resulting from targeted disruption of the Snf2 protein ATRX is mediated by p53.

Seah C, Levy MA, Jiang Y, Mokhtarzada S, Higgs DR, Gibbons RJ, Bérubé NG.

J Neurosci. 2008 Nov 19;28(47):12570-80. doi: 10.1523/JNEUROSCI.4048-08.2008.

26.

The SWI/SNF protein ATRX co-regulates pseudoautosomal genes that have translocated to autosomes in the mouse genome.

Levy MA, Fernandes AD, Tremblay DC, Seah C, Bérubé NG.

BMC Genomics. 2008 Oct 8;9:468. doi: 10.1186/1471-2164-9-468.

27.

Transcriptional regulators of chondrocyte hypertrophy.

Solomon LA, Bérubé NG, Beier F.

Birth Defects Res C Embryo Today. 2008 Jun;84(2):123-30. doi: 10.1002/bdrc.20124. Review.

PMID:
18546336
28.

Loss of ATRX leads to chromosome cohesion and congression defects.

Ritchie K, Seah C, Moulin J, Isaac C, Dick F, Bérubé NG.

J Cell Biol. 2008 Jan 28;180(2):315-24. doi: 10.1083/jcb.200706083.

29.

Patient mutations alter ATRX targeting to PML nuclear bodies.

Bérubé NG, Healy J, Medina CF, Wu S, Hodgson T, Jagla M, Picketts DJ.

Eur J Hum Genet. 2008 Feb;16(2):192-201. Epub 2007 Oct 24.

30.

Down-regulation of CD9 expression during prostate carcinoma progression is associated with CD9 mRNA modifications.

Wang JC, Bégin LR, Bérubé NG, Chevalier S, Aprikian AG, Gourdeau H, Chevrette M.

Clin Cancer Res. 2007 Apr 15;13(8):2354-61. Epub 2007 Apr 3.

31.

The retinoblastoma protein regulates pericentric heterochromatin.

Isaac CE, Francis SM, Martens AL, Julian LM, Seifried LA, Erdmann N, Binné UK, Harrington L, Sicinski P, Bérubé NG, Dyson NJ, Dick FA.

Mol Cell Biol. 2006 May;26(9):3659-71.

32.

The chromatin-remodeling protein ATRX is critical for neuronal survival during corticogenesis.

Bérubé NG, Mangelsdorf M, Jagla M, Vanderluit J, Garrick D, Gibbons RJ, Higgs DR, Slack RS, Picketts DJ.

J Clin Invest. 2005 Feb;115(2):258-67.

33.

Neurodevelopmental defects resulting from ATRX overexpression in transgenic mice.

Bérubé NG, Jagla M, Smeenk C, De Repentigny Y, Kothary R, Picketts DJ.

Hum Mol Genet. 2002 Feb 1;11(3):253-61.

PMID:
11823444
34.
35.

Assembly of a BAC contig of the complementation group B cell senescence gene candidate region at 4q33-q34.1 and identification of expressed sequences.

Bertram MJ, Bérubé NG, Swanson XH, Pereira-Smith OM.

Genomics. 1999 Mar 15;56(3):353-4. No abstract available.

PMID:
10087205
36.

Identification of a gene that reverses the immortal phenotype of a subset of cells and is a member of a novel family of transcription factor-like genes.

Bertram MJ, Bérubé NG, Hang-Swanson X, Ran Q, Leung JK, Bryce S, Spurgers K, Bick RJ, Baldini A, Ning Y, Clark LJ, Parkinson EK, Barrett JC, Smith JR, Pereira-Smith OM.

Mol Cell Biol. 1999 Feb;19(2):1479-85.

37.

Cloning and characterization of CRF, a novel C1q-related factor, expressed in areas of the brain involved in motor function.

Bérubé NG, Swanson XH, Bertram MJ, Kittle JD, Didenko V, Baskin DS, Smith JR, Pereira-Smith OM.

Brain Res Mol Brain Res. 1999 Jan 8;63(2):233-40.

PMID:
9878755
38.

The genetics of cellular senescence.

Bérubé NG, Smith JR, Pereira-Smith OM.

Am J Hum Genet. 1998 May;62(5):1015-9. Review. No abstract available.

39.

Construction and analysis of microcell hybrids containing dual selectable tagged human chromosomes.

Speevak MD, Bérubé NG, McGowan-Jordan IJ, Bisson C, Lupton SD, Chevrette M.

Cytogenet Cell Genet. 1995;69(1-2):63-5.

PMID:
7835089
40.

Supplemental Content

Loading ...
Support Center